Immunogenicity of recombinant Escherichia coli expressing the omp31 gene of Brucella melitensis in BALB/c mice

By Guilloteau L.A.   Laroucau K.   Vizcano N.   Jacques I.   Dubray G.  

Vaccine, Vol. 17, Iss. 4, 1999-02 ,pp. : 353-361

Elsevier

Access to resources Recommend Favorite

Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev. 1 live vaccines against a Brucella melitensis experimental infection in pregnant ewes

By Verger J.-M.   Grayon M.   Zundel E.   Lechopier P.   Olivier-Bernardin V.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 191-196

Elsevier

Access to resources Recommend Favorite

A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in nave and infection-primed mice

By Ruitenberg K.M.   Walker C.   Love D.N.   Wellington J.E.   Whalley J.M.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1367-1373

Elsevier

Access to resources Recommend Favorite

Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection

By Oliveira S.C.   Splitter G.A.  

Vaccine, Vol. 14, Iss. 10, 1996-07 ,pp. : 959-962

Elsevier

Access to resources Recommend Favorite

Immunogenicity of recombinant class 1 protein from Neisseria meningitidis refolded into phospholipid vesicles and detergent

By Niebla O.   Alvarez A.   Martn A.   Rodrguez A.   Delgado M.   Falcon V.   Guillen G.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3568-3574

Elsevier

Access to resources Recommend Favorite